E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 3/4/2021 in the Prospect News Bank Loan Daily.

S&P rates EyeSouth, loans B-

S&P said it assigned B- ratings to EyeSouth Partners (SCP Eye Care Services LLC) and its planned first-lien debt. The recovery rating is 3.

“Our ratings reflect the company's small scale, narrow business focus, and high leverage of around 10x in 2021, partially offset by the company's leading position in the highly fragmented ophthalmology market. Our rating reflects EyeSouth's small scale with projected revenue of about $450 million in 2021 and its narrow niche focus on ophthalmology,” the agency said in a press release.

The company’s pro forma capital structure will include a $15 million five-year revolving credit facility, undrawn at close, a $375 million seven-year senior secured first-lien term loan; and a $65 million delayed-draw first-lien term loan, undrawn at close.

Proceeds will be used to refinance debt and fund near-term acquisitions.

The outlook is stable.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.